Fat embolism in pediatric patients: an autopsy evaluation of incidence and etiology

Evert A Eriksson1, Joshua Rickey1, Stuart M Leon1

  • 1Medical University of South Carolina, Charleston, SC.

Journal of Critical Care
|October 13, 2014
PubMed

Insights

Pulmonary fat embolism (PFE) is common in pediatric deaths. Higher body mass index (BMI) independently increases the risk of PFE in children. This study analyzed fat embolism in pediatric autopsies.

Area of Science:

  • Forensic Pathology
  • Pediatric Autopsy
  • Fat Embolism

Background:

  • Limited knowledge exists regarding the incidence and causes of fat embolism in pediatric patients.
  • This study investigated pulmonary fat embolism (PFE), cerebral fat embolism (CFE), and kidney fat embolism (KFE) in pediatric autopsies.

Purpose of the Study:

  • To determine the incidence, time course, and associated factors of PFE, CFE, and KFE in pediatric trauma and nontrauma patients.
  • To identify risk factors for fat embolism in children.

Main Methods:

  • Retrospective analysis of pediatric autopsy cases (age ≤10 years) from 2008-2012.
  • Evaluation of formalin-fixed paraffin sections for fat embolism and nuclear elements by a forensic pathologist.
  • Review of autopsy reports for demographic data, cause of death, and resuscitation details.

Main Results:

  • PFE, CFE, and KFE were present in 30%, 15%, and 3% of cases, respectively.
  • Higher age, height, weight, and BMI were associated with PFE.
  • Increased body mass index (BMI) was an independent risk factor for PFE (OR 1.244).

Conclusions:

  • Fat embolism is a common finding in pediatric trauma and medical deaths.
  • Body mass index is independently associated with the development of pulmonary fat embolism.
  • Absence of nuclear elements suggests fat embolism did not originate from intramedullary fat.
Abstract

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.4K
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
20
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
736
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
729
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
532
Intestinal Obstruction II: Pathophysiology01:07

Intestinal Obstruction II: Pathophysiology

Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
25